Oral p-tert-octylphenol exposures induce minimal toxic or estrogenic effects in adult female Sprague-Dawley rats. 2010

Sukhdeep K Sahambi, and Amelie Pelland, and Gerard M Cooke, and Timothy Schrader, and Robert Tardif, and Michel Charbonneau, and Kannan Krishnan, and Sami Haddad, and Daniel G Cyr, and Patrick J Devine
INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, Laval, Québec, Canada.

Contamination of the environment with endocrine-disrupting chemicals (EDC) has raised concerns about potential health hazards for humans and wildlife. Human and wildlife exposure to one such ubiquitous chemical, p-tert-octylphenol (OP), are likely, due to its persistence in the environment and its presence in food, water, and items of daily use. OP is reported to bind to the estrogen receptor (ER) and alter expression of estrogen-responsive genes. Detrimental effects of OP exposures on the reproductive system have been observed in most, but not all, in vivo experiments. This study examined estrogenic effects of oral exposures of adult female rats to OP. In vitro, OP bound weakly to human ER and a co-activator protein, and accelerated proliferation of MCF-7 cells. Adult Sprague-Dawley rats were given OP by gavage daily for 35 d (25, 50, or 125 mg/kg/d). Body and organ weights and ovarian follicle populations were not significantly altered in OP-exposed adult rats, despite detectable levels of OP in reproductive organs. The estrous cycle of rats was slightly altered, but there were no significant estrogen-like changes in histomorphology or gene expression of the uterus. Prepubertal rats given 125 or 250 mg/kg OP by gavage for 3 d had reduced body weight compared to vehicle-exposed rats but failed to show any uterotrophic response, although 17alpha-ethinyl estradiol (EE, 10 microg/kg/d, ip) induced a threefold increase in uterine weight. Overall, results suggest that toxicity will occur before estrogenic effects with oral exposures to OP. Relevant environmental exposures likely pose little risk for estrogenic effects.

UI MeSH Term Description Entries
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D004968 Estrogens, Non-Steroidal Non-steroidal compounds with estrogenic activity. Estrogens, Nonsteroidal,Estrogens, Non Steroidal,Non-Steroidal Estrogens,Nonsteroidal Estrogens
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

Sukhdeep K Sahambi, and Amelie Pelland, and Gerard M Cooke, and Timothy Schrader, and Robert Tardif, and Michel Charbonneau, and Kannan Krishnan, and Sami Haddad, and Daniel G Cyr, and Patrick J Devine
January 2009, Journal of toxicology and environmental health. Part A,
Sukhdeep K Sahambi, and Amelie Pelland, and Gerard M Cooke, and Timothy Schrader, and Robert Tardif, and Michel Charbonneau, and Kannan Krishnan, and Sami Haddad, and Daniel G Cyr, and Patrick J Devine
July 2010, Journal of applied toxicology : JAT,
Sukhdeep K Sahambi, and Amelie Pelland, and Gerard M Cooke, and Timothy Schrader, and Robert Tardif, and Michel Charbonneau, and Kannan Krishnan, and Sami Haddad, and Daniel G Cyr, and Patrick J Devine
December 2005, Neuro endocrinology letters,
Sukhdeep K Sahambi, and Amelie Pelland, and Gerard M Cooke, and Timothy Schrader, and Robert Tardif, and Michel Charbonneau, and Kannan Krishnan, and Sami Haddad, and Daniel G Cyr, and Patrick J Devine
January 2021, Neurotoxicology and teratology,
Sukhdeep K Sahambi, and Amelie Pelland, and Gerard M Cooke, and Timothy Schrader, and Robert Tardif, and Michel Charbonneau, and Kannan Krishnan, and Sami Haddad, and Daniel G Cyr, and Patrick J Devine
January 2000, Reproductive toxicology (Elmsford, N.Y.),
Sukhdeep K Sahambi, and Amelie Pelland, and Gerard M Cooke, and Timothy Schrader, and Robert Tardif, and Michel Charbonneau, and Kannan Krishnan, and Sami Haddad, and Daniel G Cyr, and Patrick J Devine
January 1999, Archives of toxicology,
Sukhdeep K Sahambi, and Amelie Pelland, and Gerard M Cooke, and Timothy Schrader, and Robert Tardif, and Michel Charbonneau, and Kannan Krishnan, and Sami Haddad, and Daniel G Cyr, and Patrick J Devine
August 2016, Chemical research in toxicology,
Sukhdeep K Sahambi, and Amelie Pelland, and Gerard M Cooke, and Timothy Schrader, and Robert Tardif, and Michel Charbonneau, and Kannan Krishnan, and Sami Haddad, and Daniel G Cyr, and Patrick J Devine
June 2000, Toxicology and applied pharmacology,
Sukhdeep K Sahambi, and Amelie Pelland, and Gerard M Cooke, and Timothy Schrader, and Robert Tardif, and Michel Charbonneau, and Kannan Krishnan, and Sami Haddad, and Daniel G Cyr, and Patrick J Devine
January 2022, Frontiers in pharmacology,
Sukhdeep K Sahambi, and Amelie Pelland, and Gerard M Cooke, and Timothy Schrader, and Robert Tardif, and Michel Charbonneau, and Kannan Krishnan, and Sami Haddad, and Daniel G Cyr, and Patrick J Devine
July 2000, Toxicology letters,
Copied contents to your clipboard!